Ficonalkib is a potent inhibitor of Anaplastic lymphoma kinase (ALK), the tyrosine kinase receptor. Ficonalkib, can be used as an antineoplastic agent.
References:
[1]. Liu Guocheng, et al. Preparation of anaplastic lymphoma kinase inhibitor: China, CN108276410. 2018-07-13. [2]. WHO Drug Information-World Health Organization (WHO).
















